X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $87,510 | -44.5% | 80,278 | -1.3% | 0.00% | – |
Q2 2023 | $157,754 | +93.9% | 81,315 | -13.0% | 0.00% | – |
Q1 2023 | $81,344 | -0.1% | 93,497 | +14.0% | 0.00% | – |
Q4 2022 | $81,426 | -29.2% | 81,996 | +21.8% | 0.00% | – |
Q3 2022 | $115,000 | +76.9% | 67,323 | -0.2% | 0.00% | – |
Q2 2022 | $65,000 | -46.7% | 67,483 | -3.0% | 0.00% | – |
Q1 2022 | $122,000 | – | 69,599 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |